Complementary Therapies in Clinical Practice is a premier academic journal published by Elsevier Science Ltd, dedicated to advancing the field of complementary and alternative medicine. With an impressive impact factor placing it in the Q1 category for its field and a Scopus rank of 16 out of 105, it serves as a vital platform for sharing high-quality research and clinical insights. Established in 2005 and continuing through 2024, the journal is committed to disseminating evidence-based practices that enhance patient care and safety. Although it does not offer open access, the journal remains integral to researchers, clinicians, and students striving to integrate complementary therapies within conventional healthcare frameworks. Based in the United Kingdom, the journal not only promotes scholarly discourse but also fosters collaboration across an international community of practitioners dedicated to innovative therapeutic approaches.

Journal of Holistic Nursing, published by SAGE Publications Inc., is a premier academic journal dedicated to the field of nursing, specializing in holistic approaches to health and care. With an impressive impact factor and ranked in the top tier as Q1 in Nursing (miscellaneous), this journal strives to advance the science and practice of holistic nursing by publishing high-quality research, comprehensive reviews, and innovative methodologies that enrich practitioners and educators alike. Spanning from 1983 to 2024, the journal serves as an invaluable resource for researchers, professionals, and students, promoting the dissemination of knowledge and fostering a multidisciplinary understanding of holistic health practices. With a Scopus rank of #7 out of 45 in its category, the Journal of Holistic Nursing plays a vital role in shaping the future of nursing education and practice.

World Journal of Gastrointestinal Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a pivotal resource in the evolving fields of gastroenterology and oncology, particularly focused on the intricate relationship between gastrointestinal disorders and cancer. Established in 2014, the journal continues to publish influential research, boasting a commendable Q2 ranking in both the gastroenterology and oncology categories for 2023, which underscores its importance in these critical medical domains. With a diverse range of topics and studies, it serves as an essential platform for researchers, healthcare professionals, and students aiming to stay informed about the latest advancements and innovations in gastrointestinal oncology. Though currently not classified as open access, the journal's rigorous peer-review process ensures the dissemination of high-quality research that significantly contributes to clinical practice and patient care. Its positioning in the Scopus rankings also highlights its competitive standing within the scientific community, fostering discussions that are crucial for advancing both fields. Explore the latest insights and findings to enhance your understanding and contribute to the ongoing dialogue in gastrointestinal health and oncology.

Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.

Cancer Medicine is a leading open access journal published by WILEY, focusing on innovative research and advancements in the fields of Cancer Research, Oncology, and Radiology, with an impressive impact evidenced by its 2023 Q2 ranking in Cancer Research and Q1 rankings in both Oncology and Radiology, Nuclear Medicine and Imaging. With an ISSN of 2045-7634, this journal has been committed to disseminating pivotal findings since its inception in 2012, serving as a vital platform for researchers, practitioners, and students alike. The journal proudly embodies the spirit of open access, ensuring that groundbreaking cancer research is accessible to a global audience. Located in the United Kingdom, it spans a wide array of topics, promising comprehensive insights into cancer therapies, molecular mechanisms, and imaging techniques, thereby significantly contributing to the enhancement of cancer care and treatment outcomes. Researchers interested in exploring the latest advancements in cancer medicine will find this journal an indispensable resource.

JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, published by Mary Ann Liebert, Inc., stands at the forefront of research in the field of Complementary and Alternative Medicine. With an ISSN of 1075-5535 and an E-ISSN of 1557-7708, this journal has been a pivotal source of scholarly articles since its inception in 1995, although its coverage in Scopus was discontinued in 2021. Renowned for its rigorous peer-review process and high-quality contributions, the journal ranks 23rd out of 93 in the Medicine-Complementary and Alternative Medicine category, firmly positioning it in the 75th percentile. Aimed at researchers, professionals, and students, the journal provides accessible insights into the interdisciplinary studies of alternative therapies and holistic health practices. With evolving open access options, it continues to disseminate crucial knowledge that can shape future therapeutic developments and influence healthcare practices. Explore the impactful content that can support and expand your understanding of complementary medicine at JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE.

Alternative Therapies in Health and Medicine is a distinguished peer-reviewed journal, published by InnoVision Professional Media, dedicated to advancing the field of complementary and alternative medicine. Since its inception in 1995, this journal has provided a platform for the dissemination of research focusing on holistic approaches to healthcare, innovative therapies, and integrative practices. With an ISSN of 1078-6791 and an E-ISSN of 1078-6791, it offers valuable insights crucial for researchers, healthcare professionals, and students alike. While the journal currently holds a Q3 ranking in both Complementary and Alternative Medicine and Miscellaneous Medicine categories as of 2023, it aims to foster an inclusive dialogue surrounding non-conventional medical practices and their integration into mainstream health paradigms. As the journal continues its journey through 2024, it remains steadfast in its objective to enrich academic discourse and promote evidence-based alternative therapies. Access to the journal is available through institutional subscriptions, enhancing its reach within the global academic community.

CURRENT TREATMENT OPTIONS IN ONCOLOGY, published by Springer, is a premier academic journal dedicated to disseminating cutting-edge research and advancements in the field of oncology and pharmacology. With a commendable impact factor and ranked in the Q1 category in both oncology and pharmacology for 2023, this journal positions itself as a leading resource for researchers, healthcare professionals, and students alike, offering insightful reviews and original articles that critically evaluate treatment methodologies and clinical practices. Covering a wide scope of topics from early detection to innovative therapies, it fosters the translation of research findings into clinical applications. With its convergence years spanning from 2000 to 2024, CURRENT TREATMENT OPTIONS IN ONCOLOGY continues to be at the forefront of oncological research, providing a platform for scholars to explore the latest therapeutic options and improve patient outcomes. Highly regarded in the academic community, this journal is essential for anyone looking to stay informed about the dynamic landscape of cancer treatment.

Recent Patents on Anti-Cancer Drug Discovery, published by Bentham Science Publishers Ltd, is an esteemed peer-reviewed journal specializing in the innovative intersection of pharmaceutical science and oncology. With an ISSN of 1574-8928 and an E-ISSN of 2212-3970, this journal aims to provide a comprehensive platform for the dissemination of recent developments in anti-cancer drug discovery, addressing critical issues and breakthroughs that influence cancer research and treatment. The journal spans from 2006 to 2024 and is indexed in several prestigious databases, showcasing its relevance with a Q3 ranking in key categories such as Cancer Research and Drug Discovery as of 2023. Its status of being open access reflects a commitment to making valuable scientific findings widely available, promoting collaboration and advancement in the field. With a dedicated focus on advancing knowledge in cancer therapeutics, the journal serves as a vital resource for researchers, healthcare professionals, and students aiming to contribute to the fight against cancer.

The Chinese Journal of Natural Medicines, published by the esteemed CHINESE JOURNAL NATURAL MEDICINES, plays a pivotal role in the exploration and advancement of complementary and alternative medicine. With an ISSN of 2095-6975 and an E-ISSN of 1875-5364, this journal is recognized for its commitment to high-quality research and innovative findings in the realms of drug discovery and miscellaneous medical fields. Operating from China, it has earned a prestigious reputation in the academic community, achieving Q1 status in Complementary and Alternative Medicine and Q2 rankings in both Drug Discovery and Miscellaneous Medicine as of 2023, solidifying its influence within the scientific discourse. Researchers and professionals will find valuable insights here as the journal explores the intersection of traditional natural medicines with modern pharmacological science, making it an essential resource for anyone dedicated to the field. With a convergence period from 2004 to 2024, the journal continues to champion open dialogue and disseminate significant findings critical for the development of effective natural therapies.